Skip to main content

RHUMBLINE ADVISERS

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 1115418 BOSTON, MA

Position in KNSA

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$3,742,929
+$3,392,109 QoQ
Shares Held
58,529
+703.3% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 266 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 29% Shared 0% None 71%

Common Shares in KNSA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $455,921,156 across 48 Drug Manufacturers - Specialty & Generic names. KNSA ranks #16 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KNSA

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,742,929 58,529
2026-03-31 $350,820 7,286
2025-12-31 $300,547 7,286
2025-09-30 $282,915 7,286
2025-06-30 $201,603 7,286
2025-03-31 $1,392,567 62,700
2024-12-31 $1,166,129 58,955
2024-09-30 $1,496,001 59,864
2024-06-30 $1,046,752 56,066